The inhibition of oleic acid induced hepatic lipogenesis and the promotion of lipolysis by caffeic acid via up-regulation of AMP-activated kinase

Journal of the Science of Food and Agriculture

Volumn 94, Issue 6, 2014, Pages 1154-1162

  Liao, Chung Chia ^a,b   Ou, Ting Tsz ^b   Huang, Hui Pei ^b,c   Wang, Chau Jong ^b,c  

^a CHENG CHING GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

AMP activated protein kinase (AMPK); Caffeic acid (CA); Hepatic lipogenesis; Hepatic lipolysis; Non alcoholic fatty liver disease (NAFLD)

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ANTILIPEMIC AGENT; CAFFEIC ACID; CAFFEIC ACID DERIVATIVE; CHOLESTEROL; FATTY ACID SYNTHASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; OLEIC ACID; PLANT EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL;

AMP-ACTIVATED PROTEIN KINASE (AMPK); ARTICLE; CAFFEIC ACID (CA); DIET; DRUG EFFECT; FAT INTAKE; FATTY LIVER; GENE EXPRESSION; GENETICS; HEPATIC LIPOGENESIS; HEPATIC LIPOLYSIS; HEPG2 CELL LINE; HUMAN; LIPOGENESIS; LIPOLYSIS; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD); NONALCOHOLIC FATTY LIVER; PHOSPHORYLATION; UPREGULATION;

AMP-ACTIVATED PROTEIN KINASE (AMPK); CAFFEIC ACID (CA); HEPATIC LIPOGENESIS; HEPATIC LIPOLYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD);

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; CAFFEIC ACIDS; CHOLESTEROL; DIET; DIETARY FATS; FATTY ACID SYNTHESIS INHIBITORS; FATTY LIVER; GENE EXPRESSION; HEP G2 CELLS; HUMANS; HYPOLIPIDEMIC AGENTS; LIPOGENESIS; LIPOLYSIS; LIVER; OLEIC ACID; PHOSPHORYLATION; PLANT EXTRACTS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES; UP-REGULATION;

EID: 84896396354     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.6386     Document Type: Article

References (43)

1. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G and Bellentani S, Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42:44-52 (2005).
2. Farrell GC and Larter CZ, Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 43:S99-S112 (2006).
3. Starley BQ, Calcagno CJ and Harrison SA, Nonalcoholic fatty liver disease and hepatocellular carcinoma a weighty connection. Hepatology 51:1820-1832 (2010).
4. Dowman JK, Armstrong MJ, Tomlinson JW and Newsome PN, Current therapeutic strategies in non-alcoholic fatty liver disease. Diabetes Obes Metab 13:692-702 (2011).
5. Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al., Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 362:1675-1685 (2010).
6. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G and Diehl AM, Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 6:998-1003 (2000).
7. Bergeron R, Previs SF, Cline GW, Perret P, Russell 3rd RR, Young LH, et al., Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes 50:1076-1082 (2001).
8. Fogarty S and Hardie DG, Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 1804:581-591 (2010).
9. Muoio DM, Seefeld K, Witters LA and Coleman RA, AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 338:783-791 (1999).
10. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD and Parks EJ, Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343-1351 (2005).
11. Westerbacka J, Lammi K, Hakkinen AM, Rissanen A, Salminen I, Aro A, et al., Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 90:2804-2809 (2005).
12. Aray J, Rodrigo R, Videla LA, Thielemann L, Orellana M, Pettinelli P, et al., Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci (Lond) 106:635-643 (2004).
13. Yao HR, Liu J, Plumeri D, Cao YB, He T, Lin L, et al., Lipotoxicity in HepG2 cells triggered by free fatty acids. Am J Transl Res 3:284-291 (2011).
14. Svegliati-Baroni G, Candelaresi C, Saccomanno S, Ferretti G, Bachetti T, Marzioni M, et al., A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol 169:846-860 (2006).
15. Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK and Rao MS, Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 275:28918-28928 (2000).
16. Rice-Evans CA, Miller NJ and Paganga G, Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933-956 (1996).
17. Jiang RW, Lau KM, Hon PM, Mak TC, Woo KS and Fung KP, Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. Curr Med Chem 12:237-246 (2005).
18. Jayaprakasam B, Vanisree M, Zhang Y, Dewitt DL and Nair MG, Impact of alkyl esters of caffeic and ferulic acids on tumor cell proliferation, cyclooxygenase enzyme, and lipid peroxidation. J Agric Food Chem 54:5375-5381 (2006).
19. 2-induced DNA damage by chelating intracellular labile iron. J Agric Food Chem 60:7873-7879 (2012).
20. Liao HF, Chen YY, Liu JJ, Hsu ML, Shieh HJ, Liao HJ, et al., Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J Agric Food Chem 51:7907-7912 (2003).
21. Jung UJ, Lee MK, Park YB, Jeon SM and Choi MS, Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J Pharmacol Exp Ther 318:476-483 (2006).
22. Karthikesan K and Pari L, Caffeic acid alleviates the increased lipid levels of serum and tissues in alcohol-induced [hepatotoxicity in] rats. Fundam Clin Pharmacol 22:523-527 (2008).
23. Oktar S, Yonden Z, Aydin M, Ilhan S, Alcin E and Ozturk OH, Protective effects of caffeic acid phenethyl ester on iron-induced liver damage in rats. J Physiol Biochem 65:339-344 (2009).
24. Coban S, Yildiz F, Terzi A, Al B, Ozgor D, Ara C, et al., The effect of caffeic acid phenethyl ester (CAPE) against cholestatic liver injury in rats. J Surg Res 159:674-679 (2010).
25. Janbaz KH, Saeed SA and Gilani AH, Studies on the protective effects of caffeic acid and quercetin on chemical-induced hepatotoxicity in rodents. Phytomedicine 11:424-430 (2004).
26. Cousin SP, Hugl SR, Wrede CE, Kajio H, Myers Jr MG and Rhodes CJ, Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. Endocrinology 142:229-240 (2001).
27. Greenspan P, Mayer EP and Fowler SD, Nile red: A selective fluorescent stain for intracellular lipid droplets. J Cell Biol 100:965-973 (1985).
28. Bligh EG and Dyer WJ, A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917 (1959).
29. Yki-Jarvinen H, Thiazolidinediones. N Engl J Med 351:1106-1118 (2004).
30. Dowman JK, Tomlinson JW and Newsome PN, Pathogenesis of non-alcoholic fatty liver disease. Q J Med 103:71-83 (2010).
31. Horton JD, Goldstein JL and Brown MS, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125-1131 (2002).
32. Lian Z, Li Y, Gao J, Qu K, Li J, Hao L, et al., A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells. Lipids Health Dis 10:67 (2011).
33. Assifi MM, Suchankova G, Constant S, Prentki M, Saha AK and Ruderman NB, AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats. Am J Physiol Endocrinol Metab 289:E794-E800 (2005).
34. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al., Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174 (2001).
35. Rakhshandehroo M, Knoch B, Muller M and Kersten S, Peroxisome proliferator- activated receptor alpha target genes. PPAR Res 2010:612089 (2010).
36. Lee MS, Kim D, Jo K and Hwang JK, Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice. Biochem Biophys Res Commun 401:92-97 (2010).
37. Ziamajidi N, Khaghani S, Hassanzadeh G, Vardasbi S, Ahmadian S, Nowrouzi A, et al., Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARalpha and SREBP-1. Food Chem Toxicol 58:198-209 (2013).
38. Hardwick JP, Osei-Hyiaman D, Wiland H, Abdelmegeed MA and Song BJ, PPAR/RXR regulation of fatty acid metabolism and fatty acid omega-hydroxylase (CYP4) isozymes: Implications for prevention of lipotoxicity in fatty liver disease. PPAR Res 2009:952734 (2009).
39. Field FJ, Born E, Murthy S and Mathur SN, Polyunsaturated fatty acids decrease the expression of sterol regulatory element-binding protein-1 in CaCo-2 cells: effect on fatty acid synthesis and triacylglycerol transport. Biochem J 368:855-864 (2002).
40. McGarry JD and Brown NF, The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244:1-14 (1997).
41. Song S, Attia RR, Connaughton S, Niesen MI, Ness GC, Elam MB, et al., Peroxisome proliferator activated receptor alpha (PPARalpha) and PPAR gamma coactivator (PGC-1alpha) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements. Mol Cell Endocrinol 325:54-63 (2010).
42. McIntosh AL, Atshaves BP, Hostetler HA, Huang H, Davi J, Lyuksyutova OI, et al., Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes. Arch Biochem Biophys 485:160-173 (2009).
43. Atshaves BP, Storey SM, Huang H and Schroeder F, Liver fatty acid binding protein expression enhances branched-chain fatty acid metabolism. Mol Cell Biochem 259:115-129 (2004).